Details for 2018213178
Up to date per 01.04.2026
Actions
Details for 2018213178
Granted/Registered
European Patent
11.09.2019 A
23.06.2021 B1
16.05.2012
US
201261647615 P
A61K 38/00 20060101AFI20190710BHEP
Owner
Stemline Therapeutics Inc.750 Lexington Avenue, 11th Floor New York, NY 10022US
Representative
Representative
Babeluk Patentanwälte GmbHFlorianigasse 26/31080 WienAT
Inventor
CIRRITO, Thomas, P.475 48th Avenue Apt. 3703 Long Island City, NY New York 11109US
BERGSTEIN, Ivanc/o Stemline Therapeutics, Inc. 750 Lexington Avenue 11th Floor New York, NY New York 10022US
BROOKS, Christopher750 Lexington Avenue 11th Floor New York, NY New York 10022US
Information about Fees